Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis.
Reznick RM, Zong H, Li J, Morino K, Moore IK, Yu HJ, Liu ZX, Dong J, Mustard KJ, Hawley SA, Befroy D, Pypaert M, Hardie DG, Young LH, Shulman GI. · 2007
Read Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. by Reznick RM, Zong H, Li J, Morino K, Moore IK, Yu HJ, Liu ZX, Dong J, Mustard KJ, Hawley SA, Befroy D, Pypaert M, Hardie DG, Young LH, Shulman GI. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1885964.txt.
Introduction
Reznick, Shulman and co-authors reported in 2007 that aging dulls a key energy sensor in rat muscle. The sensor is AMPK, a protein kinase that boosts fat burning and orders new mitochondria, the cell's power plants. Aging already brings weaker mitochondria, messy fat handling inside cells, and insulin resistance.
In old rats, a drug that switches AMPK on, and exercise itself, both activated the muscle sensor far less than in young rats. Long-term stimulation through diet also built fewer new mitochondria in old muscle. The blunted response centered on the alpha2 form of the enzyme. The authors argue that fading AMPK activity helps explain why mitochondria falter with age. Restoring that signal is a candidate route to protect muscle metabolism in older animals and perhaps in people.
Catalog record
| CREATOR | Reznick RM, Zong H, Li J, Morino K, Moore IK, Yu HJ, Liu ZX, Dong J, Mustard KJ, Hawley SA, Befroy D, Pypaert M, Hardie DG, Young LH, Shulman GI. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Aging-Associated Reductions in AMP-Activated Protein Kinase Activity and Mitochondrial Biogenesis By Richard M Reznick, Haihong Zong, Ji Li, Katsutaro Morino, Irene K Moore, Hannah J Yu, Zhen-Xiang Liu, Jianying Dong, Kirsty J Mustard, Simon A Hawley, Douglas Befroy, Marc Pypaert Published in: Cell Metabolism DOI: 10.1016/j.cmet.2007.01.008 ABSTRACT Summary Recent studies have demonstrated a strong relationship between aging-associated reductions in mitochondrial function, dysregulated intracellular lipid metabolism, and insulin resistance. Given the important role of the AMP-activated protein kinase (AMPK) in the regulation of fat oxidation and mitochondrial biogenesis, we examined AMPK activity in young and old rats and found that acute stimulation of AMPK-α2 activity by 5′-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) and exercise was blunted in skeletal muscle of old rats. Furthermore, mitochondrial biogenesis in response to chronic activation of AMPK with β-guanidinopropionic acid (β-GPA) feeding was also diminished in old rats. These results suggest that aging-associated reductions in AMPK activity may be an important contributing factor in the reduced mitochondrial function and dysregulated intracellular lipid metabolism associated with aging. Keywords: HUMDISEASE INTRODUCTION The AMP-activated protein kinase (AMPK) is emerging as a chief regulator of whole-body energy balance (Bolster et al., 2002, Holmes et al., 1999, Kahn et al., 2005, Kimura et al., 2003, Krause et al., 2002, Terada et al., 2002, Winder et al., 1997, Winder et al., 2000). In skeletal muscle, once AMPK becomes activated, it exerts control in part by regulating fatty-acid oxidation through the phosphorylation of acetyl-CoA carboxylase 2 (ACC2) and mitochondrial biogenesis through increasing the expression of proteins vital for proper mitochondrial function such as citrate synthase and succinate dehydrogenase (Bergeron et al., 2001, Merrill et al., 1997, Winder et al., 1997, Winder et al., 2000, Zong et al., 2002). Reductions in mitochondrial oxidative-phosphorylation activity, which contribute to dysregulated intracellular lipid metabolism, have recently been implicated in the increased incidence of insulin resistance and type 2 diabetes that occurs with aging (Petersen et al., 2003). Given the critical role that AMPK plays in the regulation of mitochondrial biogenesis and fatty-acid oxidation, we examined the effect of aging on the AMPK signaling pathway and mitochondrial biogenesis during acute pharmacological stimulation, exercise, and chronic pharmacological stimulation. RESULTS AND DISCUSSION AICAR Infusions 5′-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) is an acute activator of AMPK, which is taken up into cells and converted into 5′-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside monophosphate (ZMP), which mimics the effects of AMP on AMPK (Corton et al., 1995). When bound to AMPK, AMP or ZMP induces a conformational change that makes AMPK a better substrate for activation by the upstream kinase LKB1 (Hawley et al., 2003). In vivo AICAR infusions in 3-month-old (“young”) and 28-month-old (“old”) Fisher 344 male rats increased AMPK-α2 activity by 44% in the extensor digitalis longus (EDL) muscles of the young AICAR-treated rats versus young saline-treated (control) rats (Figure 1A). In contrast, AICAR infusions did not increase AMPK-α2 activity in the old rats, demonstrating reduced AMPK activation with aging. Furthermore, AMPK phosphorylation of one of its key substrates in skeletal muscle, ACC2, at serine 79 (Ser79) was increased by 120% in the young AICAR-treated rats, whereas there was no difference in the old AICAR-treated rats (Figure 1B). [Figure: The Effect of AICAR Infusions on AMPK and LKB1 in Young and Old Rats(A) AMPK-α2 activity in the EDL muscle of young and old rats infused with either AICAR or saline (control). AMPK-α2 activity was increased by 44% in the young AICAR-treated rats compared to the young saline-treated rats. In contrast, there was no difference between the old AICAR-treated and saline-treated rats. (n = 7–10 in each group.) ∗p = 0.01. In this and all other figures, values are presented as means ± SEM.(B) p-ACC (Ser79) in the EDL muscle of young and old rats infused with either AICAR or saline (control). AICAR infusion resulted in a 120% increase in p-ACC (Ser79) in the young rats. In contrast, there was no effect of AICAR infusion on p-ACC (Ser79) in the old rats. (n = 4–6 in each group.) ∗p < 0.05.(C) p-AMPK (Thr172) in the EDL muscle of young and old rats infused with either AICAR or saline (control). AICAR infusion resulted in a 162% increase in p-AMPK (Thr172) in the young rats. In contrast, there was no effect of AICAR infusion on p-AMPK (Thr172) in the old rats. (n = 4–6 in each group.) ∗p < 0.05.(D) LKB1 protein expression in the EDL muscle of young and old rats infused with either AICAR or saline (control). LKB1 protein expression in EDL muscle of young and old rats did not differ significantly during aging or in response to AICAR infusion. (n = 4 in each group.)(E) LKB1 activity in the EDL muscle of young and old rats infused with either AICAR or saline (control). LKB1 activity in the EDL muscle of young and old rats did not differ significantly during aging or in response to AICAR infusion. (n = 4 in each group.)] AMPK activity is regulated by the phosphorylation of threonine 172 (Thr172) on the catalytic α subunit of the enzyme (Hawley et al., 1996), and studies in tissue-specific mouse knockouts suggest that LKB1 is the major upstream kinase in skeletal muscle, at least for α2 (Sakamoto et al., 2005). The reduced AICAR-stimulated AMPK-α2 activity could be attributed to reduced phosphorylation since Thr172 phosphorylation increased by 162% in the young AICAR-treated rats and was unaltered in the old AICAR-treated rats (Figure 1C). These aging-associated differences in AMPK-α2 activity and Thr172 phosphorylation between AICAR-treated and saline-treated rats were independent of any changes in AMPK-α1 activity or in the expression of the AMPK-α1 and α2 subunits (see Figure S1 in the Supplemental Data available with this article online). They also were not associated with changes in the expression (Figure 1D) or activity of LKB1 (Figure 1E) or in the phosphorylation of Ser491 on AMPK-α2 (data not shown), which has been reported to antagonize phosphorylation at Thr172 (Horman et al., 2006). LKB1 occurs as long and short polypeptides (Hawley et al., 2003), which have recently been identified as splice variants (S.A.H. and D.G.H., unpublished data). Although the two forms were expressed in almost equal amounts in rat skeletal muscle by western blotting, their expression was not different in the old rats. Exercise Exercise or contraction rapidly depletes ATP, which leads to the increase in the AMP:ATP ratio that is responsible for causing AMPK activation (Sakamoto et al., 2005, Winder and Hardie, 1996). Groups of young and old Fisher 344 male rats that had been exercise trained for 5 days completed a 5-day treadmill exercise regimen that resulted in a 110% increase in AMPK-α2 activity in the young rats. In contrast, the old rats displayed severely blunted AMPK-α2 activity in response to exercise (Figure 2A). Additionally, phosphorylation of Ser79 on ACC2 was blunted in the old rats despite a 127% increase in the young rats (Figure 2B). Lastly, Thr172 phosphorylation increased 55% in the young exercising rats and did not change in the old exercising rats compared to their controls (Figure 2C). These aging-associated differences in AMPK-α2 activity and Thr172 phosphorylation between exercising rats and sedentary rats were independent of any changes in AMPK-α1 activity or in the expression of the AMPK-α1 and α2 subunits (Figure S1). [Figure: The Effect of Exercise on AMPK in Young and